Matches in Wikidata for { <http://www.wikidata.org/entity/Q74286179> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q74286179 description "clinical trial" @default.
- Q74286179 description "ensayu clínicu" @default.
- Q74286179 description "klinisch onderzoek" @default.
- Q74286179 description "клінічне випробування" @default.
- Q74286179 name "A Study of TAK-981 in Combination With Rituximab in Participants With Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL)" @default.
- Q74286179 name "A Study of TAK-981 in Combination With Rituximab in Participants With Relapsed/Refractory" @default.
- Q74286179 type Item @default.
- Q74286179 label "A Study of TAK-981 in Combination With Rituximab in Participants With Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL)" @default.
- Q74286179 label "A Study of TAK-981 in Combination With Rituximab in Participants With Relapsed/Refractory" @default.
- Q74286179 prefLabel "A Study of TAK-981 in Combination With Rituximab in Participants With Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL)" @default.
- Q74286179 prefLabel "A Study of TAK-981 in Combination With Rituximab in Participants With Relapsed/Refractory" @default.
- Q74286179 P1050 Q74286179-9CA8B8D7-83A9-4B16-A91F-6F2179C4259E @default.
- Q74286179 P1132 Q74286179-A642780A-316E-49C4-AC27-F0E5022CB7E8 @default.
- Q74286179 P1476 Q74286179-AD78AD96-C2F3-4540-A9EC-20C735451FB5 @default.
- Q74286179 P17 Q74286179-781A6908-2A5E-469A-8149-093A5E42E541 @default.
- Q74286179 P2899 Q74286179-390F2714-5F60-4033-9B96-39311D1D7AFB @default.
- Q74286179 P3098 Q74286179-9C32214C-5D82-41F6-A89B-095359F1FEC3 @default.
- Q74286179 P31 Q74286179-0D170BB8-9850-411A-9C67-983E1DC076EF @default.
- Q74286179 P4844 Q74286179-1C742461-E55B-46A0-8569-4DE98608D2A2 @default.
- Q74286179 P580 Q74286179-E45491B9-FD6D-4ABA-A0FA-EA048E5B25BE @default.
- Q74286179 P582 Q74286179-927767A0-D6A3-4E72-87CA-2A3ED7CB8A6C @default.
- Q74286179 P6099 Q74286179-411DF778-D571-419F-9571-8A3A5B1D959F @default.
- Q74286179 P6099 Q74286179-8A2B6FC6-8990-4025-AB69-A61D5C721DCC @default.
- Q74286179 P8363 Q74286179-1C28CBAB-7A29-4E3E-916E-A1A9C2DC5889 @default.
- Q74286179 P1050 Q208414 @default.
- Q74286179 P1132 "+90" @default.
- Q74286179 P1476 "Phase 1b/2 Study of TAK-981 in Combination With Rituximab in Patients With Relapsed/Refractory CD20-positive Non-Hodgkin Lymphoma" @default.
- Q74286179 P17 Q30 @default.
- Q74286179 P2899 "+18" @default.
- Q74286179 P3098 "NCT04074330" @default.
- Q74286179 P31 Q30612 @default.
- Q74286179 P4844 Q412323 @default.
- Q74286179 P580 "2019-10-15T00:00:00Z" @default.
- Q74286179 P582 "2023-08-19T00:00:00Z" @default.
- Q74286179 P6099 Q42824440 @default.
- Q74286179 P6099 Q5452194 @default.
- Q74286179 P8363 Q78089383 @default.